{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:27:19Z","timestamp":1768094839879,"version":"3.49.0"},"reference-count":28,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2006,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To measure the effect of low\u2010dose systemic glucocorticoid treatment on the adrenal response to adrenocorticotropic hormone (ACTH) in patients with rheumatoid arthritis (RA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients with RA who took part in a randomized double\u2010blind placebo\u2010controlled trial of budesonide (3 mg\/day and 9 mg\/day) and prednisolone (7.5 mg\/day) underwent a short (60\u2010minute) test with injection of ACTH (tetracosactide hexaacetate) at baseline and the day after completing the 3\u2010month treatment program. Plasma cortisol measurements at baseline and 3 months were compared within and between the treatment groups. Individual patients were classified as normal responders to ACTH or as abnormal responders if changes were &gt;2 SD below the pretreatment value in the entire group of study patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Short tests with ACTH injection were performed on 139 patients before beginning the study medication and on 134 patients after cessation of the medication. There were no changes in the placebo group. Mean plasma cortisol levels following treatment were reduced in all active treatment groups. In addition, mean values were significantly reduced for the 30\u2010minute and 60\u2010minute responses to ACTH. The maximum reduction (35%) occurred in the prednisolone group at 60 minutes. Following treatment, 34% of patients taking budesonide 9 mg and 46% of those taking prednisolone 7.5 mg failed to reach the normal maximum cortisol response to ACTH. Four patients failed to achieve the normal percentage increase in cortisol levels, but only 1 patient failed to meet both criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Low doses of a glucocorticoid resulted in depression of baseline and ACTH\u2010stimulated cortisol levels after 12 weeks of therapy. Although the responsiveness of the hypothalamic\u2013pituitary\u2013adrenal axis in individual patients generally remained within the normal range, these changes should be investigated further.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.21747","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T16:57:56Z","timestamp":1146157076000},"page":"1415-1421","source":"Crossref","is-referenced-by-count":39,"title":["The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis"],"prefix":"10.1002","volume":"54","author":[{"given":"John R.","family":"Kirwan","sequence":"first","affiliation":[]},{"given":"Sarah H.","family":"Hickey","sequence":"additional","affiliation":[]},{"given":"Roger","family":"H\u00e4llgren","sequence":"additional","affiliation":[]},{"given":"Herman","family":"Mielants","sequence":"additional","affiliation":[]},{"given":"Ewa","family":"Bj\u00f6rck","sequence":"additional","affiliation":[]},{"given":"Tore","family":"Persson","sequence":"additional","affiliation":[]},{"given":"Frank A.","family":"Wollheim","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"Effects of a hormone of the adrenal cortex (17\u2010hydroxy\u201011 deoxycorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis: preliminary report","volume":"24","author":"Hench PS","year":"1949","journal-title":"Proc Staff Meetings Mayo Clinic"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197607012950107"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(61)92830-6"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(63)91383-7"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(65)91526-6"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0340411"},{"key":"e_1_2_5_8_2","first-page":"261","article-title":"Corticosteroid\u2010induced suppression of the hypothalamic\u2010pituitary\u2010adrenal axis: observations on patients given oral corticosteroids for rheumatoid arthritis","volume":"36","author":"Jasani MK","year":"1967","journal-title":"Q J Med"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.27.1.33"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.8.718"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/15.1.17"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.008573"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_5_14_2","first-page":"A695","article-title":"Pharmacokinetics and gastrointestinal transit of budesonide controlled ileal release (CIR) capsules","volume":"104","author":"Edsbacker S","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)27565-7"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409293311304"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1994.1058"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00555.x"},{"key":"e_1_2_5_19_2","first-page":"24","article-title":"Adrenal secretion of cortisol in patients with rheumatoid arthritis","volume":"17","author":"Neeck G","year":"1990","journal-title":"J Rheumatol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351107"},{"key":"e_1_2_5_21_2","first-page":"596","article-title":"Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis: effects of glucocorticoids","volume":"23","author":"Gudbjornsson B","year":"1996","journal-title":"J Rheumatol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1461"},{"key":"e_1_2_5_23_2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1210\/jcem.82.4.3852","article-title":"Circadian relationships between interleukin (IL)\u20106 and hypothalamic\u2010pituitary\u2010adrenal axis hormones: failure of IL\u20106 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis","volume":"82","author":"Crofford LJ","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.4.298"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1780055"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201233260403"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(79)91077-8"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06290-X"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199507203330302"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.21747","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.21747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:07:55Z","timestamp":1736359675000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.21747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,27]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1002\/art.21747"],"URL":"https:\/\/doi.org\/10.1002\/art.21747","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,27]]}}}